TOP NEWS: AstraZeneca's subsidiary enters agreement with Neurimmune Read More
AstraZeneca transfers rights to Eklira and Duaklir for USD270 million Read More
LONDON MARKET PRE-OPEN: Eyes on Fed minutes; Astra seals drug transfer Read More
UK retailers boosted as new year brings shoppers back to high street Read More
Worst of pandemic is "absolutely behind us", says UK vaccine scientist Read More
LONDON MARKET MIDDAY: London catches up on post-Christmas rally Read More
LONDON MARKET OPEN: Stocks positive, shrugging off record Covid cases Read More
TOP NEWS: AstraZeneca signs deal with Ionis for eplontersen treatment Read More
LONDON MARKET PRE-OPEN: Astra strikes deal; Round Hill lassos Moon Read More
IN BRIEF: Redx shares up on USD9 million milestone payment from Astra Read More
LONDON MARKET MIDDAY: Stocks buoyed by Covid studies and treatments Read More
TOP NEWS: Third dose of AstraZeneca vaccine boosts Omicron antibodies Read More
AstraZeneca's treatment Ultomiris gets priority review from US FDA Read More
AstraZeneca's lupus drug Saphnelo recommended for EU approval Read More
LONDON MARKET PRE-OPEN: Former Tesco chief to chair Glaxo consumer Read More
TOP NEWS: Astra's Covid antibody retains activity against Omicron Read More
LONDON BROKER RATINGS: Deutsche cuts Abrdn; UBS raises Dunelm Read More
TOP NEWS: GSK, Sanofi Covid jab booster shows strong immune response Read More
UK Cabinet minister warns of "concerning situation" as Omicron spreads Read More
UK virus cases highest since January with 58,000 new cases on Friday Read More
